Skip to main content
. Author manuscript; available in PMC: 2015 Aug 4.
Published in final edited form as: J Clin Cell Immunol. 2014 Nov 19;5(6):1000273. doi: 10.4172/2155-9899.1000273

Figure 6.

Figure 6

The serum pro-inflammatory and anti-inflammatory cytokine levels of mice treated with PBS and CII-BPI-2 on day 31. Mice treated with three injections of CII-BPI-2 have significantly lower levels of pro-inflammatory cytokines (e.g., IFN-γ, IL-17, and TNF-α) in serum than those injected with PBS (*, p<0.01 and ‡, p<0.001). Furthermore, serum IL-10 levels were significantly higher (p<0.001) in CII-BPI-2 groups compared to the control group.